137 related articles for article (PubMed ID: 38750435)
1. Breaking the Mucin Barrier: A New Affinity Chromatography-Mass Spectrometry Approach to Unveil Potential Cell Markers and Pathways Altered in Pseudomyxoma Peritonei.
Romero-Ruiz A; Granados-Rodríguez M; Bura FI; Valenzuela-Molina F; Rufián-Andújar B; Martínez-López A; Rodríguez-Ortiz L; Ortega-Salas R; Torres-Martínez M; Moreno-Serrano A; Castaño J; Michán C; Alhama J; Vázquez-Borrego MC; Arjona-Sánchez Á
Biol Proced Online; 2024 May; 26(1):13. PubMed ID: 38750435
[TBL] [Abstract][Full Text] [Related]
2. Strategies for Preventing Pseudomyxoma Peritonei After Resection of a Mucinous Neoplasm of the Appendix.
Honoré C; Caruso F; Dartigues P; Benhaim L; Chirica M; Goéré D; Elias D
Anticancer Res; 2015 Sep; 35(9):4943-7. PubMed ID: 26254392
[TBL] [Abstract][Full Text] [Related]
3. Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy for Pseudomyxoma Peritonei Arising from Urachus.
Liu Y; Ishibashi H; Hirano M; Takeshita K; Mizumoto A; Ichinose M; Nishino E; Kashu I; Yamamoto Y; Sugarbaker PH; Yonemura Y
Ann Surg Oncol; 2015 Aug; 22(8):2799-805. PubMed ID: 25572681
[TBL] [Abstract][Full Text] [Related]
4. Feasibility of peritonectomy associated with intraperitoneal hyperthermic perfusion in patients with Pseudomyxoma peritonei.
Deraco M; Gronchi A; Mazzaferro V; Inglese MG; Pennacchioli E; Kusamura S; Rizzi M; Anselmi RA; Vaglini M
Tumori; 2002; 88(5):370-5. PubMed ID: 12487553
[TBL] [Abstract][Full Text] [Related]
5. Intraoperative oxygen tension and redox homeostasis in Pseudomyxoma peritonei: A short case series.
Valenzuela-Molina F; Bura FI; Vázquez-Borrego MC; Granados-Rodríguez M; Rufián-Andujar B; Rufián-Peña S; Casado-Adam Á; Sánchez-Hidalgo JM; Rodríguez-Ortiz L; Ortega-Salas R; Martínez-López A; Michán C; Alhama J; Arjona-Sánchez Á; Romero-Ruiz A
Front Oncol; 2023; 13():1076500. PubMed ID: 36776312
[TBL] [Abstract][Full Text] [Related]
6. Ovarian mature teratomas with mucinous epithelial neoplasms: morphologic heterogeneity and association with pseudomyxoma peritonei.
McKenney JK; Soslow RA; Longacre TA
Am J Surg Pathol; 2008 May; 32(5):645-55. PubMed ID: 18344868
[TBL] [Abstract][Full Text] [Related]
7. Unusual site of pseudomyxoma peritonei recurrence after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: a case report of intraluminal disease manifestation in the small bowel.
Rauwerdink P; Brosens LAA; van Diepen KK; Ghedri ON; Kranenburg O; Boerma D; Witkamp AJ; van Grevenstein HMU
World J Surg Oncol; 2022 May; 20(1):147. PubMed ID: 35538541
[TBL] [Abstract][Full Text] [Related]
8. [Pseudomyxoma peritonei (PMP) secondary to mucinous carcinoma of the ovary: a case study].
Belhamidi MS; Zorkani Y; Krimou H; Kaoukabi A; Menfaa M; Sakit F; Choho K
Pan Afr Med J; 2019; 33():283. PubMed ID: 31692896
[TBL] [Abstract][Full Text] [Related]
9. Recommendations in the management of epithelial appendiceal neoplasms and peritoneal dissemination from mucinous tumours (pseudomyxoma peritonei).
Barrios P; Losa F; Gonzalez-Moreno S; Rojo A; Gómez-Portilla A; Bretcha-Boix P; Ramos I; Torres-Melero J; Salazar R; Benavides M; Massuti T; Aranda E
Clin Transl Oncol; 2016 May; 18(5):437-48. PubMed ID: 26489426
[TBL] [Abstract][Full Text] [Related]
10. Pseudomyxoma peritonei and an incidental low-grade appendiceal mucinous neoplasm and neuroendocrine appendiceal collision tumour: a case report.
Gupta A; Mirpuri L; Malik F; Hassan H; Amtul N
J Surg Case Rep; 2023 May; 2023(5):rjad281. PubMed ID: 37251256
[TBL] [Abstract][Full Text] [Related]
11. Recurrence and outcome after complete tumour removal and hyperthermic intraperitoneal chemotherapy in 512 patients with pseudomyxoma peritonei from perforated appendiceal mucinous tumours.
Lord AC; Shihab O; Chandrakumaran K; Mohamed F; Cecil TD; Moran BJ
Eur J Surg Oncol; 2015 Mar; 41(3):396-9. PubMed ID: 25216980
[TBL] [Abstract][Full Text] [Related]
12. Establishment and characterization of NCC-PMP2-C1: a novel patient-derived cell line of pseudomyxoma peritonei with signet ring cells.
Noguchi R; Yoshimatsu Y; Sin Y; Ono T; Tsuchiya R; Yoshida H; Kiyono T; Yonemura Y; Kondo T
Hum Cell; 2024 Mar; 37(2):511-522. PubMed ID: 38143259
[TBL] [Abstract][Full Text] [Related]
13. Pseudomyxoma peritonei (PMP) and its therapy - 20 years experience of a single surgical department.
Bartoška P; Antoš F; Vítek P; Marx J; Holečková P; Novotný M; Kengbaeva M
Rozhl Chir; 2020; 99(4):159-166. PubMed ID: 32545978
[TBL] [Abstract][Full Text] [Related]
14. Ovarian mucinous tumour arising in mature cystic teratoma and associated with pseudomyxoma peritonei: report of two cases and comparison with ovarian involvement by low-grade appendiceal mucinous tumour.
Stewart CJ; Tsukamoto T; Cooke B; Leung YC; Hammond IG
Pathology; 2006 Dec; 38(6):534-8. PubMed ID: 17393980
[TBL] [Abstract][Full Text] [Related]
15. The Cancer Diaspora: A Rare Case of Pseudomyxoma Peritonei of Appendiceal Origin.
Bathobakae L; Ozgur SS; Jariwala M; Kesrani J; Ajas S; Kumar M; Akmal A
J Investig Med High Impact Case Rep; 2023; 11():23247096231217822. PubMed ID: 38102072
[TBL] [Abstract][Full Text] [Related]
16. A case of pseudomyxoma peritonei arising from a perforated intraductal papillary mucinous neoplasm that underwent cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
Yoshizaki Y; Gohda Y; Inagaki F; Kataoka A; Takemura N; Miyazaki H; Igari T; Kiyomatsu T; Yano H; Kokudo N
Clin J Gastroenterol; 2024 Feb; 17(1):188-197. PubMed ID: 37980306
[TBL] [Abstract][Full Text] [Related]
17. Progress in Biological Research and Treatment of Pseudomyxoma Peritonei.
Li X; Liu G; Wu W
Cancers (Basel); 2024 Apr; 16(7):. PubMed ID: 38611084
[TBL] [Abstract][Full Text] [Related]
18. MUC2 is a molecular marker for pseudomyxoma peritonei.
O'Connell JT; Hacker CM; Barsky SH
Mod Pathol; 2002 Sep; 15(9):958-72. PubMed ID: 12218214
[TBL] [Abstract][Full Text] [Related]
19. Patients with pseudomyxoma peritonei associated with disseminated peritoneal adenomucinosis have a significantly more favorable prognosis than patients with peritoneal mucinous carcinomatosis.
Ronnett BM; Yan H; Kurman RJ; Shmookler BM; Wu L; Sugarbaker PH
Cancer; 2001 Jul; 92(1):85-91. PubMed ID: 11443613
[TBL] [Abstract][Full Text] [Related]
20. Rare occurrence of pseudomyxoma peritonei (PMP) syndrome arising from a malignant transformed ovarian primary mature cystic teratoma treated by cytoreductive surgery and HIPEC: a case report.
Ponzini F; Kowal L; Ghafoor M; Goldberg A; Chan J; Lamm R; Cannaday SM; Richard SD; Nevler A; Lavu H; Bowne WB; Rosenblum NG
World J Surg Oncol; 2022 Mar; 20(1):78. PubMed ID: 35272690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]